In the latest sign of how entrenched the nation's epidemic of painkiller misuse has become, people are also abusing treatments meant to cure their addiction. Titan Pharmaceuticals Inc. plans to file for Food and Drug Administration approval in September for a matchstick-size implant of buprenorphine,...
FULL ARTICLE AT Asian Wall Street Journal